Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/SU6656> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- SU6656 abstract "SU6656 is a Src family kinase inhibitor developed by the biotechnology company SUGEN Inc (a subsidiary of Pharmacia) in 2000. SU6656 was initially identified as a Src kinase inhibitor by virtue of its ability to reverse an effect that an activated mutant form of Src (hu SRC Y530F) has on the actin cytoskeleton, namely the formation of podosome rosettes, otherwise known as invadopodia. SU6656 was initially published as a Src family kinase inhibitor with selectivity relative to Platelet-derived growth factor receptor Tyrosine kinase. Subsequent studies have confirmed that SU6656 is relatively selective for Src family kinases but some additional biochemical activities have been identified including: BRSK2, AMPK, Aurora C, Aurora B, CaMKKβ. The inhibition of these kinases in biochemical reactions in vitro does not necessarily indicate that these kinases are targets of SU6656 in cells.SU6656 has been used primarily as a research tool to investigate the function of Src family kinases in cellular signal transduction processes and biology.".
- SU6656 iupacName "(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulfonamide".
- SU6656 thumbnail SU6656.svg?width=300.
- SU6656 wikiPageID "26096334".
- SU6656 wikiPageLength "2996".
- SU6656 wikiPageOutDegree "13".
- SU6656 wikiPageRevisionID "679042066".
- SU6656 wikiPageWikiLink Actin.
- SU6656 wikiPageWikiLink Category:Articles_created_via_the_Article_Wizard.
- SU6656 wikiPageWikiLink Category:Protein_kinase_inhibitors.
- SU6656 wikiPageWikiLink Category:Sulfonamides.
- SU6656 wikiPageWikiLink Cytoskeleton.
- SU6656 wikiPageWikiLink Invadopodia.
- SU6656 wikiPageWikiLink Pharmacia.
- SU6656 wikiPageWikiLink Platelet-derived_growth_factor_receptor.
- SU6656 wikiPageWikiLink Podosome.
- SU6656 wikiPageWikiLink Protein_kinase_inhibitor.
- SU6656 wikiPageWikiLink Proto-oncogene_tyrosine-protein_kinase_Src.
- SU6656 wikiPageWikiLink SUGEN.
- SU6656 wikiPageWikiLink Tyrosine_kinase.
- SU6656 wikiPageWikiLinkText "SU6656".
- SU6656 imagefile "SU6656.svg".
- SU6656 imagesize "200".
- SU6656 iupacname "-N,N-Dimethyl-2-oxo-3--2,3-dihydro-1H-indole-5-sulfonamide".
- SU6656 wikiPageUsesTemplate Template:Cascite.
- SU6656 wikiPageUsesTemplate Template:Chembox.
- SU6656 wikiPageUsesTemplate Template:Chembox_Hazards.
- SU6656 wikiPageUsesTemplate Template:Chembox_Identifiers.
- SU6656 wikiPageUsesTemplate Template:Chembox_Properties.
- SU6656 wikiPageUsesTemplate Template:Confusing.
- SU6656 wikiPageUsesTemplate Template:Reflist.
- SU6656 subject Category:Articles_created_via_the_Article_Wizard.
- SU6656 subject Category:Protein_kinase_inhibitors.
- SU6656 subject Category:Sulfonamides.
- SU6656 hypernym Inhibitor.
- SU6656 type ChemicalCompound.
- SU6656 type ChemicalSubstance.
- SU6656 type Drug.
- SU6656 type Amide.
- SU6656 type Inhibitor.
- SU6656 type Sulfonamide.
- SU6656 type ChemicalObject.
- SU6656 type Thing.
- SU6656 type Q11173.
- SU6656 comment "SU6656 is a Src family kinase inhibitor developed by the biotechnology company SUGEN Inc (a subsidiary of Pharmacia) in 2000. SU6656 was initially identified as a Src kinase inhibitor by virtue of its ability to reverse an effect that an activated mutant form of Src (hu SRC Y530F) has on the actin cytoskeleton, namely the formation of podosome rosettes, otherwise known as invadopodia.".
- SU6656 label "SU6656".
- SU6656 sameAs Q7394936.
- SU6656 sameAs اسیو۶۶۵۶.
- SU6656 sameAs m.0dgsjkb.
- SU6656 sameAs SU6656.
- SU6656 sameAs SU6656.
- SU6656 sameAs Q7394936.
- SU6656 wasDerivedFrom SU6656?oldid=679042066.
- SU6656 depiction SU6656.svg.
- SU6656 isPrimaryTopicOf SU6656.